Assessment of regulatory needs list

Assessment of regulatory needs list

The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed. 

For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.

The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.  

Last updated 03 May 2024. Database contains 5017 unique substances/entries.
Filter the list
Foreseen regulatory need:
Date of intention:
Date of assessment:
Latest update:

The List does not contain any Substances.
 
939-412-9
-
ECHA
Under development
No action
28-Aug-2023
Details
944-243-9
-
ECHA
Under development
No action
28-Aug-2023
Details
922-670-1
-
ECHA
Under development
No action
02-Apr-2024
Details
947-329-4
-
ECHA
Under development
No action
28-Aug-2023
Details
422-750-1
-
ECHA
Under development
No action
27-Oct-2023
Details
421-970-5
-
ECHA
Under development
No action
13-Jul-2022
Details
701-065-4
-
ECHA
CLH
17-Oct-2022
Details
425-060-9
-
ECHA
Under development
CLH
Other action
16-Dec-2021
Details
701-017-2
-
ECHA
Under development
CCH
16-Jan-2023
Details
-
-
ECHA
Under development
Pending action
26-Jul-2021
Details
466-490-7
-
Sweden
Toxic for reproduction
Concluded
CLH
02-Jul-2021
Details
-
-
ECHA
Under development
No action
05-Jul-2022
Details
-
-
ECHA
Under development
No action
05-Jul-2022
Details
451-200-3
-
ECHA
Under development
No action
05-Jul-2022
Details
429-200-1
-
ECHA
Under development
CCH
CLH
15-Dec-2022
Details
REAKTIV BRILLANTROT F 54 846 FW
401-090-8
-
ECHA
Under development
Pending action
18-May-2021
Details
443-520-7
-
ECHA
Under development
No action
17-Dec-2021
Details
-
-
ECHA
Under development
No action
16-Dec-2021
Details
700-575-4
-
ECHA
Under development
No action
11-Jan-2022
Details
435-770-0
-
ECHA
Under development
No action
13-Jul-2022
Details
700-166-0
-
ECHA
Under development
CLH
18-Nov-2022
Details
468-740-0
-
ECHA
Under development
Other action
Other action
16-Dec-2021
Details
947-787-5
-
ECHA
Concluded
No action
10-Nov-2021
Details
TIBSC
454-150-0
-
ECHA
Under development
No action
18-Dec-2023
Details
946-440-5
-
ECHA
Under development
No action
25-Mar-2021
Details
-
-
ECHA
Under development
Pending action
22-Dec-2023
Details
show/hide
Phenol, 4-nonyl-, phosphite (3:1) EC / List no: 608-492-4 | CAS no: 3050-88-2
Tris(nonylphenyl) phosphite EC / List no: 247-759-6 | CAS no: 26523-78-4
Phenol, p-isononyl-, phosphite (3:1) EC / List no: - | CAS no: 31631-13-7
Phenol, p-sec-nonyl-, phosphite EC / List no: - | CAS no: 106599-06-8
tris(4-nonylphenyl, branched) phosphite EC / List no: 701-028-2 | CAS no: -
799-976-5
-
France
Endocrine disruption
Skin sensitiser
Concluded
SVHC
29-Apr-2019
Details
701-028-2
-
ECHA
Under development
CCH
28-Jan-2022
Details
476-490-9
-
ECHA
Under development
CCH
13-Jul-2022
Details
700-978-5
-
ECHA
Under development
No action
13-Dec-2021
Details
701-354-5
-
ECHA
Under development
Pending action
02-May-2022
Details
434-150-7
-
ECHA
Under development
CLH
12-Jan-2024
Details
show/hide
Sodium undecafluorohexanoate EC / List no: 220-881-7 | CAS no: 2923-26-4
-
-
Germany
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
Restriction
07-Dec-2017
Details
426-780-6
-
ECHA
Under development
No action
13-Sep-2022
Details
949-084-9
-
ECHA
Under development
CLH
Other action
19-May-2021
Details
945-749-2
-
ECHA
Under development
Pending action
19-May-2021
Details
418-730-7
-
ECHA
Under development
CCH
20-Mar-2024
Details
436-680-4
-
ECHA
Under development
No action
16-Jan-2024
Details
416-270-1
-
ECHA
Under development
No action
13-Dec-2023
Details
947-961-0
-
ECHA
Under development
Pending action
31-Mar-2023
Details
950-052-1
-
ECHA
Under development
No action
03-Mar-2022
Details
202-815-9
100-06-1
ECHA
Under development
CCH
28-Feb-2023
Details
202-826-9
100-18-5
ECHA
Under development
Pending action
15-Dec-2023
Details
202-830-0
100-21-0
France
Endocrine disruption
Concluded
None
07-Mar-2017
Details
202-830-0
100-21-0
ECHA
Under development
CCH
26-Jul-2021
Details
202-848-9
100-40-3
ECHA
Under development
Pending action
11-Dec-2023
Details
202-849-4
100-41-4
ECHA
Under development
CLH
Other legislation
25-Sep-2023
Details
202-851-5
100-42-5
Under development
Pending action
15-Nov-2022
Details
202-851-5
100-42-5
Denmark
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
No suggestion yet
Details
202-851-5
100-42-5
Netherlands
STOT RE
Concluded
CLH
SVHC
Other
13-May-2022
Details

Export search results to: